Inactief instrument

Andere talen Medipharm Labs Corp Toronto S.E.

Aandelen

CA58504D1006

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

MediPharm Labs Narrows Q4 Loss, Revenue Grows; Up 10.5%	27/03
MediPharm Labs Provides Conference Call Recording Details	27/03
MediPharm Labs Narrows Q4 Loss, Revenue Grows	27/03
MediPharm Labs Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
MediPharm Labs Corp. Brief: Q4 Revenue $9.131 Million; Says Annual Revenue and Adjusted EBITDA Improve by 50%	27/03
MediPharm Labs Reports Fourth Quarter and Full Year Results	27/03
MediPharm Labs Offers Update on German Cannabis Legalization; Up Nearly 6%	25/03
IM Cannabis Corp. Brief: Notes This Provides IMC Germany with a "Unique Opportunity" to further accelerate growth in 2024 after delivering 180% growth in 2023	25/03
IM Cannabis Corp. Brief: Adds By rescheduling medical cannabis, from a narcotic to a regular prescription, the German medical cannabis market is Expected to deliver "Strong" growth	25/03
IM Cannabis Corp. Brief: Says Expects "Accelerated Growth" in Germany from that Country's "Groundbreaking" Cannabis Legalization	25/03
MediPharm Labs Offers Update on German Cannabis Legalization	25/03
MediPharm Labs Corp. Brief: Says "Historic change is a significant positive step in removing the stigma related to medical cannabis"	25/03
MediPharm Labs Corp. Brief: Providing Update on German Cannabis Legalization	25/03
MediPharm Labs Provides Update on German Cannabis Legalization	25/03
MediPharm Labs Provides Update on German Cannabis Legalization	25/03
MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2023 Financial Results	22/03
MediPharm Labs Corp. Says Achieved Pharmaceutical GMP Certification with Brazilian Health Authority	07/02
MediPharm Labs Corp. Brief: Says Achieved Pharmaceutical GMP Certification with Brazilian Health Authority	07/02
MediPharm Labs Achieves Pharmaceutical GMP Certification with Brazilian Health Authority	07/02
MediPharm Labs Provides Update on Board of Directors and Long Term Incentive Program	22/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Medipharm Labs Corp Toronto S.E.

Aandelen

CA58504D1006

Andere talen

Filters